Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             32 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer Yasuda, Hiroyuki

162 C p. 140-146
artikel
2 CCL19 associates with lymph node metastasis and inferior prognosis in patients with small cell lung cancer Liu, Qian

162 C p. 194-202
artikel
3 Clinical implementation of value based healthcare: Impact on outcomes for lung cancer patients Demedts, Ingel

162 C p. 90-95
artikel
4 Coexistence of a novel NBEA-ALK, EML4-ALK double-fusion in a lung adenocarcinoma patient and response to alectinib: A case report Liang, Qi

162 C p. 86-89
artikel
5 Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations Bazhenova, Lyudmila

162 C p. 154-161
artikel
6 Comprehensive metastatic ablation in advanced NSCLC through biology-guided radiotherapy – A path forward? Filippi, Andrea R.

162 C p. 203-206
artikel
7 Contents
162 C p. iv-vi
artikel
8 Corrigendum to “Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions” [Lung Cancer 159 (2021) 66–73] Mondaca, Sebastian

162 C p. 210
artikel
9 Corrigendum to “eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer” [Lung Cancer 160 (2021) 36–43] Buma, Alessandra I.G.

162 C p. 211
artikel
10 Cryobiopsy as a reliable technique for the preoperative identification of micropapillary/solid components in early-stage lung adenocarcinoma Suzuki, Mikito

162 C p. 147-153
artikel
11 Diverse responses to EGFR-TKIs in patients with concurrent germline and somatic EGFR mutations Wu, Yifen

162 C p. 207-209
artikel
12 Editorial Board
162 C p. iii
artikel
13 Effect of epidermal growth factor receptor gene mutation on the prognosis of pathological stage II–IIIA (8th edition TNM classification) primary lung cancer after curative surgery Isaka, Tetsuya

162 C p. 128-134
artikel
14 Electronic patient-reported outcomes monitoring during lung cancer chemotherapy: A nested cohort within the PRO-TECT pragmatic trial (AFT-39) Mody, Gita N.

162 C p. 1-8
artikel
15 Immune checkpoint inhibitor therapy for malignant pleural mesothelioma Nowak, Anna K

162 C p. 162-168
artikel
16 Impact of treatment timing and sequence of immune checkpoint inhibitors and anti-angiogenic agents for advanced non-small cell lung cancer: A systematic review and meta-analysis Matsumoto, Kinnosuke

162 C p. 175-184
artikel
17 In vitro validation study of HER2 and HER4 mutations identified in an ad hoc secondary analysis of the LUX-Lung 8 randomized clinical trial Hamada, Akira

162 C p. 79-85
artikel
18 Lung cancer-associated T cell repertoire as potential biomarker for early detection of stage I lung cancer Li, Min

162 C p. 16-22
artikel
19 Molecular testing in stage I–III non-small cell lung cancer: Approaches and challenges Aggarwal, Charu

162 C p. 42-53
artikel
20 Phase 1 multicenter study of the HSP90 inhibitor SNX-5422 plus carboplatin and paclitaxel in patients with lung cancers Gutierrez, Martin

162 C p. 23-28
artikel
21 Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis Fjaellegaard, Katrine

162 C p. 106-118
artikel
22 Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital Gao, Lin

162 C p. 54-60
artikel
23 Prophylactic cranial irradiation (PCI), hippocampal avoidance (HA) whole brain radiotherapy (WBRT) and stereotactic radiosurgery (SRS) in small cell lung cancer (SCLC): Where do we stand? Crockett, Cathryn

162 C p. 96-105
artikel
24 Quality of life after VATS lung resection and SABR for early-stage non-small cell lung cancer: A longitudinal study Pompili, Cecilia

162 C p. 71-78
artikel
25 Risk factors of nephrotoxicity of maintenance pemetrexed in patients with metastatic non-squamous non-small cell carcinoma of lung Kwok, Wang Chun

162 C p. 169-174
artikel
26 Sequential afatinib and osimertinib in patients with EGFR mutation-positive NSCLC and acquired T790M: A global non-interventional study (UpSwinG) Popat, Sanjay

162 C p. 9-15
artikel
27 The effect of home-based preoperative pulmonary rehabilitation before lung resection: A retrospective cohort study Saito, Takashi

162 C p. 135-139
artikel
28 The effect of tumor size and metastatic extent on the efficacy of first line pembrolizumab monotherapy in patients with high PD-L1 expressing advanced NSCLC tumors Schakenraad, Alexandra

162 C p. 36-41
artikel
29 Thoracic surgery improved overall survival in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinoma who received and responded to tyrosine kinase inhibitor treatment Chien, Yu-Ning

162 C p. 29-35
artikel
30 Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013–2017: A nationwide CAS registry analysis from the I-O Optimise initiative Baas, Paul

162 C p. 185-193
artikel
31 Treatment strategies for unresectable locally advanced non-small cell lung cancer in the real-life ESME cohort Girard, Nicolas

162 C p. 119-127
artikel
32 Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands Evers, Jelle

162 C p. 61-70
artikel
                             32 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland